PIB TrackerTB incidence down 21 per cent, and a third panchayat figure in a week
A backgrounder puts India ahead of the global decline on WHO figures, with 28.1 crore screenings - and 46,118 certified TB-free panchayats, after two releases said 67,933.
What happened
- India’s new TB cases fell 21 per cent from 2015 to 2024 against a global 12 per cent, and deaths fell 28 per cent, on the WHO Global TB Report 2025.
- Treatment coverage is 92 per cent against global coverage of 78 per cent.
- Under TB Mukt Bharat Abhiyaan: 28.1 crore cumulative screenings, over 20 lakh on TB preventive treatment, 5.7 lakh new Nikshay Mitras and 46,118 gram panchayats certified TB-free.
- Delivery changes named: a 34-fold increase in handheld X-ray screening, the TB Mukt Bharat App with an AI chatbot, and the BPaLM regimen for drug-resistant TB.
- The JOSH teams - MY Bharat volunteers, NCC cadets and a Class-I officer - ran a nationwide campaign across 55 districts in 11 States.
For Prelims
- The programme: the National TB Elimination Programme, with a stated national target of 2025 against the global Sustainable Development Goal target of 2030 - the most ambitious disease-elimination timeline India has set itself.
- Incidence against prevalence: incidence is new cases arising in a year; prevalence is cases existing at a point in time. A 21 per cent fall in incidence means fewer people are being infected, which is the harder measure to move.
- Treatment coverage: notified and treated cases as a share of estimated incidence. It rises when case-finding improves, so a higher figure means fewer "missing" patients outside the system - not that treatment outcomes improved.
- Nikshay: the national TB patient management system; Nikshay Poshan Yojana pays a monthly nutrition allowance to patients on treatment, and Nikshay Mitra lets individuals and organisations adopt patients for nutritional support.
- BPaLM: a six-month all-oral regimen for drug-resistant TB, replacing regimens that ran up to two years with injectables. Shorter and oral matters because the main cause of resistance is treatment interrupted halfway.
- Why handheld X-ray changes case-finding: TB screening historically required a patient to reach a facility with a fixed machine. A battery-powered unit with AI-assisted reading takes the screening to the village, which is what a 34-fold increase describes.
- Drug-resistant TB: MDR-TB is resistance to isoniazid and rifampicin, the two strongest first-line drugs; XDR-TB adds resistance to fluoroquinolones and other second-line agents. India carries a large share of the global burden.
- TB Mukt Panchayat: a certification given to panchayats meeting criteria on case notification, screening and treatment outcomes - which is a different test from a panchayat being "recognised", and is why two counts can both be true and must be labelled.
For UPSC: The cleanest consolidated statement of India’s TB position, sourced to the WHO report rather than to a ministry claim. Deploy it on health policy and disease elimination targets, on the 2025 target slipping towards 2030, on community participation in public health, and as a caution on citing a scheme figure that has appeared in three different forms inside one week.
What it is NOT: The backgrounder does not reconcile 46,118 certified panchayats with the 67,933 recognised as TB Mukt reported twice the previous week, and defines neither term. No absolute incidence or mortality figures, only percentage declines, so the burden itself is invisible. No treatment success rate as distinct from coverage - the number that says whether people finish their course. Nothing on how many of the 28.1 crore screenings produced a diagnosis, and no figure for drug-resistant cases or for BPaLM coverage among them.
For Mains
Syllabus: GS2.13 · GS2.10 · Linkage L1
Anchor
A PIB backgrounder puts India’s TB incidence down 21 per cent between 2015 and 2024 against a global decline of 12 per cent, with deaths down 28 per cent and treatment coverage at 92 per cent against a global 78, on WHO Global TB Report 2025 figures.
Substantiation (data)
Cumulative screenings have crossed 28.1 crore, over 20 lakh people have received preventive treatment, 5.7 lakh new Nikshay Mitras have been added and 46,118 gram panchayats hold TB-free certification. Case-finding has been pushed by a 34-fold increase in handheld X-ray screening, and drug-resistant patients now receive the six-month oral BPaLM regimen.
Position
Two of these figures are the programme’s real achievements and are often confused. Treatment coverage at 92 per cent means case-finding has closed most of the gap between estimated and notified patients - the missing-millions problem that defined Indian TB control for a decade. The shift to a six-month all-oral regimen for drug-resistant TB addresses the other half, because resistance is manufactured by treatment that people cannot complete.
Counterpoint
The panchayat figure is a warning about reading scheme numbers. This release reports 46,118 panchayats certified TB-free; releases on 7 and 8 October both reported 67,933 recognised as TB Mukt, and dated the same figure to 2025 in one and 2026 in the other. Certification and recognition may well be different stages, but no release says so, and a number that appears in three forms in a week cannot be cited without the source attached.
Way forward
The figure that would settle progress is treatment success rate, not coverage - what share of notified patients complete and are cured. For the 2025 target now effectively running to 2030, that and the drug-resistant caseload are the two series worth following, alongside whether JOSH’s 55-district pilot produces a measurable change in notification.
Conclusion
India is genuinely ahead of the global trend on the measures WHO publishes. The scheme-side counting is where the reporting is weakest, and this week produced three versions of one number to prove it.
Deploys into: TB elimination and health targets · Case-finding and treatment coverage · Drug resistance and regimen design · Reading inconsistent scheme figures
PIB Backgrounder (Ministry of Health and Family Welfare) · 2026-10-13 · PRID 2322820 · PIB source ↗